Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial

Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations are now presented under a single 'Locations' section, grouping sites by state and replacing the previous per-state location subsections. Prospective participants can more easily identify all participating sites at a glance.
    Difference
    1%
    Check dated 2025-12-23T08:43:14.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    New locations have been added (Mineola, NY – Site 129; UNC Chapel Hill) and the total number of locations is now 25, with the Mineola site listed as Not yet Recruiting. The Houston, TX site and the Medical College of Wisconsin – Froedtert Hospital have been removed.
    Difference
    2%
    Check dated 2025-12-08T22:59:00.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T17:03:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Phase 1/1B dose escalation and Phase 1b Sub-studies 1-4 plus Sub-study 5 were added, with MRTX1719 as the intervention on specified days. Enrollment updated to 336 and key study dates (primary and study completion) set to 2027-12-10, with new documents and IPD sharing information (CSR, SAP, IPD sharing URL) added.
    Difference
    2%
    Check dated 2025-11-17T15:04:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant changes to the study details; only non-critical metadata such as the last update timestamp appears updated, while core data like enrollment, primary endpoints, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:30:54.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and updated version to v3.2.0; removed reference to v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:27:33.000Z thumbnail image

Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.